Kim CA - Search Results

1

Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic Cancer.

Tsang ES, Spratlin J, Cheung WY, Kim CA, Kong S, Xu Y, Gill S. Tsang ES, et al. Among authors: kim ca. Am J Clin Oncol. 2019 Dec;42(12):903-908. doi: 10.1097/COC.0000000000000625. Am J Clin Oncol. 2019. PMID: 31693510

2

Real-world impact of availability of adjuvant therapy on outcomes in patients with resected pancreatic adenocarcinoma: a Canadian Cancer Agency experience.

Kim C, Owen D, Gill S. Kim C, et al. Am J Clin Oncol. 2012 Jun;35(3):212-5. doi: 10.1097/COC.0b013e318209d36c. Am J Clin Oncol. 2012. PMID: 21358297

3

Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.

Kim CA, Price-Hiller J, Chu QS, Tankel K, Hennig R, Sawyer MB, Spratlin JL. Kim CA, et al. Invest New Drugs. 2014 Oct;32(5):1036-45. doi: 10.1007/s10637-014-0113-6. Epub 2014 May 23. Invest New Drugs. 2014. PMID: 24853074

4

Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience.

Kim CA, Spratlin JL, Armstrong DE, Ghosh S, Mulder KE. Kim CA, et al. Clin Colorectal Cancer. 2014 Sep;13(3):199-206. doi: 10.1016/j.clcc.2014.06.002. Epub 2014 Jun 26. Clin Colorectal Cancer. 2014. PMID: 25088184

5

How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.

Kim C, Mulder K, Spratlin J. Kim C, et al. Oncologist. 2014 Oct;19(10):1046-55. doi: 10.1634/theoncologist.2014-0006. Epub 2014 Aug 20. Oncologist. 2014. PMID: 25142842 Free PMC article. Review.

6

Effects of gender on capecitabine toxicity in colorectal cancer.

Ilich AI, Danilak M, Kim CA, Mulder KE, Spratlin JL, Ghosh S, Chambers CR, Sawyer MB. Ilich AI, et al. Among authors: kim ca. J Oncol Pharm Pract. 2016 Jun;22(3):454-60. doi: 10.1177/1078155215587345. Epub 2015 May 22. J Oncol Pharm Pract. 2016. PMID: 26002954

7

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients.

Sun J, Ilich AI, Kim CA, Chu MP, Wong GG, Ghosh S, Danilak M, Mulder KE, Spratlin JL, Chambers CR, Sawyer MB. Sun J, et al. Among authors: kim ca. Clin Colorectal Cancer. 2016 Sep;15(3):257-63. doi: 10.1016/j.clcc.2015.12.008. Epub 2015 Dec 28. Clin Colorectal Cancer. 2016. PMID: 26803708

8

Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta.

Kim CA, Chu QSC, Fassbender K, Ghosh S, Spratlin JL. Kim CA, et al. Am J Clin Oncol. 2018 Sep;41(9):867-873. doi: 10.1097/COC.0000000000000385. Am J Clin Oncol. 2018. PMID: 28368922

9

Efficacy and Tolerability of Second-line Nab-paclitaxel and Gemcitabine After Failure of First-line FOLFIRINOX for Advanced Pancreas Cancer: A Single-institution Experience.

Zhang H, Kellett C, Lambert P, Kim CA. Zhang H, et al. Among authors: kim ca. Clin Colorectal Cancer. 2018 Sep;17(3):e451-e456. doi: 10.1016/j.clcc.2018.03.003. Epub 2018 Mar 8. Clin Colorectal Cancer. 2018. PMID: 29631907

10

Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy.

Rittberg R, Zhang H, Lambert P, Kudlovich R, Kim CA, Dawe DE. Rittberg R, et al. Among authors: kim ca. J Geriatr Oncol. 2021 Jan;12(1):112-117. doi: 10.1016/j.jgo.2020.07.004. Epub 2020 Aug 11. J Geriatr Oncol. 2021. PMID: 32798212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters